SCHEMBL25161985

SCHEMBL25161985

CC(=O)OCC(=Cc1ccc(C(C)(C)C)cc1)COC(C)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 5/20 0.40
ALDH1A1 P00352 4/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 1/20 0.40
TRPV1 Q8NER1 5/20 0.40
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
EPHX2 P34913 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
RECQL P46063 2/20 0.36
ALOX15 P16050 1/20 0.36
APEX1 P27695 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998126 0.92 CYP1A2 (0.41) CYP1A2SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL9998124 0.92 CYP1A2 (0.41) CYP1A2SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL9998449 0.90 CYP1A2 (0.40) CYP1A2SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL9998448 0.90 CYP1A2 (0.40) CYP1A2SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL9997585 0.87 CYP1A2 (0.45) CYP1A2SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL9997587 0.87 CYP1A2 (0.45) CYP1A2SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL9997754 0.86 LMNA (0.45) CYP1A2SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL9997752 0.86 LMNA (0.45) CYP1A2SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL9998161 0.83 CYP1A2 (0.41) CYP1A2SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL13410929 0.79 GSK3B (0.47) CYP1A2SMN1; SMN2ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230121556-A1 COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE TAGWORKS PHARMACEUTICALS B.V. (NL) 2023-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230121556-A1 COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE LTB4R, LTC4S, LTA4H CYP1A2 2001/4885SMN1; SMN2 3664/4885LMNA 3805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.